Literature DB >> 33766126

Two distinct conformers of PrPD type 1 of sporadic Creutzfeldt-Jakob disease with codon 129VV genotype faithfully propagate in vivo.

Ignazio Cali1,2, Juan Carlos Espinosa3, Satish K Nemani4, Alba Marin-Moreno3, Manuel V Camacho5, Rabail Aslam5, Tetsuyuki Kitamoto6, Brian S Appleby5,7,8,9, Juan Maria Torres3, Pierluigi Gambetti5.   

Abstract

Current classifications of sporadic Creutzfeldt-Jakob disease (sCJD) identify five subtypes associated with different disease phenotypes. Most of these histopathological phenotypes (histotypes) co-distribute with distinct pairings of methionine (M)/valine (V) genotypes at codon 129 of the prion protein (PrP) gene and the type (1 or 2) of the disease-associated PrP (PrPD). Types 1 and 2 are defined by the molecular mass (~ 21 kDa and ~ 19 kDa, respectively) of the unglycosylated isoform of the proteinase K-resistant PrPD (resPrPD). We recently reported that the sCJDVV1 subtype (129VV homozygosity paired with PrPD type 1, T1) shows an electrophoretic profile where the resPrPD unglycosylated isoform is characterized by either one of two single bands of ~ 20 kDa (T120) and ~ 21 kDa (T121), or a doublet of ~ 21-20 kDa (T121-20). We also showed that T120 and T121 in sCJDVV have different conformational features but are associated with indistinguishable histotypes. The presence of three distinct molecular profiles of T1 is unique and raises the issue as to whether T120 and T121 represent distinct prion strains. To answer this question, brain homogenates from sCJDVV cases harboring each of the three resPrPD profiles, were inoculated to transgenic (Tg) mice expressing the human PrP-129M or PrP-129V genotypes. We found that T120 and T121 were faithfully replicated in Tg129V mice. Electrophoretic profile and incubation period of mice challenged with T121-20 resembled those of mice inoculated with T121 and T120, respectively. As in sCJDVV1, Tg129V mice challenged with T121 and T120 generated virtually undistinguishable histotypes. In Tg129M mice, T121 was not replicated while T120 and T121-20 generated a ~ 21-20  kDa doublet after lengthier incubation periods. On second passage, Tg129M mice incubation periods and regional PrP accumulation significantly differed in T120 and T121-20 challenged mice. Combined, these data indicate that T121 and T120 resPrPD represent distinct human prion strains associated with partially overlapping histotypes.

Entities:  

Keywords:  Histotype; Lesion profile; Plaques; Prion protein; Prion strain; Transmission properties; sCJDVV1

Year:  2021        PMID: 33766126      PMCID: PMC7995586          DOI: 10.1186/s40478-021-01132-7

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


  46 in total

1.  MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain.

Authors:  Fabio Moda; Silvia Suardi; Giuseppe Di Fede; Antonio Indaco; Lucia Limido; Chiara Vimercati; Margherita Ruggerone; Ilaria Campagnani; Jan Langeveld; Alessandro Terruzzi; Antonio Brambilla; Pietro Zerbi; Paolo Fociani; Matthew T Bishop; Robert G Will; Jean C Manson; Giorgio Giaccone; Fabrizio Tagliavini
Journal:  Brain Pathol       Date:  2012-02-21       Impact factor: 6.508

2.  Drug resistance confounding prion therapeutics.

Authors:  David B Berry; Duo Lu; Michal Geva; Joel C Watts; Sumita Bhardwaj; Abby Oehler; Adam R Renslo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

3.  Amyloid fibrils from the N-terminal prion protein fragment are infectious.

Authors:  Jin-Kyu Choi; Ignazio Cali; Krystyna Surewicz; Qingzhong Kong; Pierluigi Gambetti; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

4.  PrP conformational transitions alter species preference of a PrP-specific antibody.

Authors:  Wen-Quan Zou; Jan Langeveld; Xiangzhu Xiao; Shugui Chen; Patrick L McGeer; Jue Yuan; Michael C Payne; Hae-Eun Kang; John McGeehan; Man-Sun Sy; Neil S Greenspan; David Kaplan; Gong-Xian Wang; Piero Parchi; Edward Hoover; Geoff Kneale; Glenn Telling; Witold K Surewicz; Qingzhong Kong; Jian-Ping Guo
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

5.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 7.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

Review 8.  Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.

Authors:  Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Neuropathology       Date:  2015-12-15       Impact factor: 1.906

9.  Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.

Authors:  Marcello Rossi; Daniela Saverioni; Michele Di Bari; Simone Baiardi; Afina Willemina Lemstra; Laura Pirisinu; Sabina Capellari; Annemieke Rozemuller; Romolo Nonno; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2017-11-23       Impact factor: 7.801

10.  Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.

Authors:  Jérôme Chapuis; Mohammed Moudjou; Fabienne Reine; Laetitia Herzog; Emilie Jaumain; Céline Chapuis; Isabelle Quadrio; Jacques Boulliat; Armand Perret-Liaudet; Michel Dron; Hubert Laude; Human Rezaei; Vincent Béringue
Journal:  Acta Neuropathol Commun       Date:  2016-02-05       Impact factor: 7.801

View more
  2 in total

Review 1.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

2.  Generation of human chronic wasting disease in transgenic mice.

Authors:  Zerui Wang; Kefeng Qin; Manuel V Camacho; Ignazio Cali; Jue Yuan; Pingping Shen; Justin Greenlee; Qingzhong Kong; James A Mastrianni; Wen-Quan Zou
Journal:  Acta Neuropathol Commun       Date:  2021-09-26       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.